GW Pharmaceuticals PLC (NASDAQ:GWPH) reported earnings of ($2.08) per share missing Walls Streets expectations.

ME Staff
-
0

GW Pharmaceuticals PLC (NASDAQ:GWPH) reported 6/30/2017 earnings this Afternoon, coming in at ($2.08) per share, missing Wall Street’s estimates of ($1.73) per Share. Revenue for the quarter came in at $3.14 million beating analyst estimates of $2.10 million

Analyst Coverage For GW Pharmaceuticals PLC (NASDAQ:GWPH)
These are 1 Hold Rating, 7 Buy Ratings .
The current consensus rating for GW Pharmaceuticals PLC (NASDAQ:GWPH) is Buy (Score: 2.88) with a consensus target price of $161.71 , a potential (40.50% upside)



      Recent Trading for GW Pharmaceuticals PLC (NASDAQ:GWPH)
      Shares of GW Pharmaceuticals PLC closed the previous trading session at 115.10 down -2.51 -2.13% with 687,554 shares trading hands.